{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:42:00Z","timestamp":1793263320762,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007705","name":"Astellas Pharma Global Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.05.079","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T16:24:36Z","timestamp":1654791876000},"page":"4190-4198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Phase 1\/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years"],"prefix":"10.1016","volume":"40","author":[{"given":"Gurunadh R.","family":"Chichili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Cywin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kovanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Van Sant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Malinoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shite","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Siber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.05.079_b0005","series-title":"StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2020","article-title":"Streptococcus pneumoniae","author":"Dion","year":"2020"},{"key":"10.1016\/j.vaccine.2022.05.079_b0010","unstructured":"Centers for Disease Control and Prevention National Notifiable Diseases Surveillance System. Invasive Pneumococcal Disease (IPD) (Streptococcus pneumoniae) 2017 Case Definition. Available from: https:\/\/ndc.services.cdc.gov\/case-definitions\/invasive-pneumococcal-disease-2017\/. Accessed April 20, 2022."},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2022.05.079_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2012.03937.x","article-title":"Understanding the burden of pneumococcal disease in adults","volume":"18","author":"Blasi","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2022.05.079_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.079_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cis359","article-title":"Pneumococcal conjugate vaccine for adults: a new paradigm","volume":"55","author":"Paradiso","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.079_b0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/mi.2016.41","article-title":"Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection","volume":"10","author":"Wang","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.079_b0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41385-019-0218-5","article-title":"Generation of protective pneumococcal-specific nasal resident memory CD4(+) T cells via parenteral immunization","volume":"13","author":"O\u2019Hara","year":"2020","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.079_b0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.079_b0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/INF.0000000000002567","article-title":"A phase 1 randomized, placebo-controlled, observer-blinded trial to evaluate the safety and immunogenicity of inactivated streptococcus pneumoniae whole-cell vaccine in adults","volume":"39","author":"Keech","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2022.05.079_b0050","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/vaccines9111338","article-title":"Pneumococcal vaccines: past findings, present work, and future strategies","volume":"9","author":"Oliveira","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"33","key":"10.1016\/j.vaccine.2022.05.079_b0055","doi-asserted-by":"crossref","first-page":"13564","DOI":"10.1073\/pnas.1307228110","article-title":"Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.079_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1773-y","article-title":"Characteristics of serogroup 20 S.pneumoniae isolates from Brazil","volume":"16","author":"Caier\u00e3o","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"33","key":"10.1016\/j.vaccine.2022.05.079_b0065","doi-asserted-by":"crossref","first-page":"27885","DOI":"10.1074\/jbc.M112.380451","article-title":"Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype","volume":"287","author":"Calix","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2022.05.079_b0070","article-title":"Role of pneumococcal proteins SP1500 and SP0785 in colonization, virulence and immunity","author":"Moujaes","year":"2020","journal-title":"Eur Soc Paediatric Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.079_b0075","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.079_b0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/CVI.00086-12","article-title":"Development of a fourfold multiplexed opsonophagocytosis assay for pneumococcal antibodies against additional serotypes and discovery of serological subtypes in Streptococcus pneumoniae serotype 20","volume":"19","author":"Burton","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2022.05.079_b0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4155\/bio-2020-0024","article-title":"Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes","volume":"12","author":"Nolan","year":"2020","journal-title":"Bioanalysis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.079_b0090","doi-asserted-by":"crossref","first-page":"e00128","DOI":"10.1128\/mSphere.00128-18","article-title":"Development and validation of 13-plex luminex-based assay for measuring human serum sntibodies to Streptococcus pneumoniae capsular polysaccharides","volume":"3","author":"Pavliakova","year":"2018","journal-title":"mSphere"},{"issue":"9807","key":"10.1016\/j.vaccine.2022.05.079_b0095","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2022.05.079_b0100","doi-asserted-by":"crossref","first-page":"e00490","DOI":"10.1128\/IAI.00490-18","article-title":"Screening for Th17-dependent pneumococcal vaccine antigens: comparison of murine and human cellular immune responses","volume":"86","author":"Lu","year":"2018","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.079_b0105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4161\/hv.27998","volume":"10","author":"Juergens","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.079_b0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/21645515.2018.1532250","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults \u226565 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"15","author":"Peterson","year":"2019","journal-title":"Hum Vaccin Immunother"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2024.05.071","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T21:43:49Z","timestamp":1656452629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":22,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22007150"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1\/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}